Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"

Juan C Rosas^{1

2}, Miguel E Aguado-Barrera³, David Azria⁴, Erik Briers⁵, Rebecca Elliott⁶, Marie-Pierre Farcy-Jacquet⁷, Alexandra Giraldo⁸, Sara Gutiérrez-Enríquez⁹, Tiziana Rancati¹⁰, Tim Rattay¹¹, Victoria Reyes⁸, Barry Rosenstein¹², Dirk De Ruysscher^{13

14}, Elena Sperk¹⁵, Hilary Stobart¹⁶, Christopher Talbot¹¹, Ana Vega^{3

17}, Begoña Taboada-Valladares^{3

18}, Liv Veldeman^{19

20}, Tim Ward²¹, Adam Webb¹¹, Catharine West⁶, Jenny Chang-Claude^{1

22}, Petra Seibold¹; REQUITE Consortium

Affiliations

¹ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
² Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians University, Munich, Germany.
³ Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
⁴ University of Montpellier, INSERM U1194 IRCM, Institut du Cancer Montpellier (ICM), Montpellier, France.
⁵ Patient advocate, Hasselt, Belgium.
⁶ University of Manchester, Manchester, UK.
⁷ Federation Universitaire d'Oncologie Radiothérapie d'Occitanie Méditerranée, Institut du Cancer Du Gard (ICG), CHU Carémeau, Nîmes, France.
⁸ Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
⁹ Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
¹⁰ Istituto Nazionale dei Tumori, Data Science Unit, Milan, Italy.
¹¹ University of Leicester, Leicester, UK.
¹² Icahn School of Medicine at Mount Sinai, New York, New York, USA.
¹³ Maastro Clinic, Maastricht, The Netherlands.
¹⁴ KU Leuven, Leuven, Belgium.
¹⁵ Universitätsmedizin Mannheim, Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
¹⁶ Independent Cancer Patients' Voice, London, UK.
¹⁷ Biomedical Network on Rare Diseases (CIBERER), Seville, Spain.
¹⁸ Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
¹⁹ Ghent University Hospital, Ghent, Belgium.
²⁰ Ghent University, Ghent, Belgium.
²¹ NCRI CTRad Consumer, London, UK.
²² University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 37908014
DOI: 10.1002/ijc.34772

Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"

Juan C Rosas et al. Int J Cancer. 2024.

. 2024 Feb 15;154(4):759-761.

doi: 10.1002/ijc.34772. Epub 2023 Oct 31.

Authors

Affiliations

¹ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
² Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians University, Munich, Germany.
³ Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
⁴ University of Montpellier, INSERM U1194 IRCM, Institut du Cancer Montpellier (ICM), Montpellier, France.
⁵ Patient advocate, Hasselt, Belgium.
⁶ University of Manchester, Manchester, UK.
⁷ Federation Universitaire d'Oncologie Radiothérapie d'Occitanie Méditerranée, Institut du Cancer Du Gard (ICG), CHU Carémeau, Nîmes, France.
⁸ Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
⁹ Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
¹⁰ Istituto Nazionale dei Tumori, Data Science Unit, Milan, Italy.
¹¹ University of Leicester, Leicester, UK.
¹² Icahn School of Medicine at Mount Sinai, New York, New York, USA.
¹³ Maastro Clinic, Maastricht, The Netherlands.
¹⁴ KU Leuven, Leuven, Belgium.
¹⁵ Universitätsmedizin Mannheim, Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
¹⁶ Independent Cancer Patients' Voice, London, UK.
¹⁷ Biomedical Network on Rare Diseases (CIBERER), Seville, Spain.
¹⁸ Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
¹⁹ Ghent University Hospital, Ghent, Belgium.
²⁰ Ghent University, Ghent, Belgium.
²¹ NCRI CTRad Consumer, London, UK.
²² University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 37908014
DOI: 10.1002/ijc.34772

No abstract available

PubMed Disclaimer

References

REFERENCES

1. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005;23(27):6613-6622. doi:10.1200/jco.2005.07.024
1. Courtier N, Gambling T, Enright S, Barrett-Lee P, Abraham J, Mason MD. Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer. 2012;21(1):173-181. doi:10.1007/s00520-012-1508-6
1. Taunk NK, Haffty BG, Chen S, et al. Comparison of radiation-induced fatigue across 3 different radiotherapeutic methods for early stage breast cancer. Cancer. 2011;117(18):4116-4124. doi:10.1002/cncr.26013
1. Wratten C, Kilmurray J, Nash S, et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys. 2004;59(1):160-167. doi:10.1016/j.ijrobp.2003.10.008
1. Dhruva A, Dodd M, Paul SM, et al. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs. 2010;33(3):201-212. doi:10.1097/NCC.0b013e3181c75f2a

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"

Affiliations

Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"

Authors

Affiliations

References

REFERENCES

Publication types

LinkOut - more resources

Full Text Sources